{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:43:23Z","timestamp":1793706203221,"version":"4.6.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1053\/j.ajkd.2020.03.023","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T06:15:31Z","timestamp":1590819331000},"page":"546-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":226,"title":["NSAIDs in CKD: Are They Safe?"],"prefix":"10.1053","volume":"76","author":[{"given":"Megan","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2020.03.023_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2215\/CJN.06520714","article-title":"Chronic pain and analgesic use in CKD: implications for patient safety","volume":"10","author":"Wu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3109\/0886022X.2013.801272","article-title":"Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy","volume":"35","author":"Bilge","year":"2013","journal-title":"Ren Fail"},{"key":"10.1053\/j.ajkd.2020.03.023_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.ajkd.2016.08.039","article-title":"Pain management in CKD: a guide for nephrology providers","volume":"69","author":"Koncicki","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1053\/j.ajkd.2020.03.023_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib6","first-page":"F829","article-title":"Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons","volume":"252","author":"Nath","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib7","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.3399\/bjgp14X680557","article-title":"Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice","volume":"64","author":"Hull","year":"2014","journal-title":"Br J Gen Pract"},{"key":"10.1053\/j.ajkd.2020.03.023_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000339439","article-title":"Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease","volume":"36","author":"Patel","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2215\/CJN.05180418","article-title":"Clinical pharmacology considerations in pain management in patients with advanced kidney failure","volume":"14","author":"Davison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2215\/CJN.12311216","article-title":"Patterns of NSAIDs use and their association with other analgesic use in CKD","volume":"12","author":"Zhan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000441-200103000-00005","article-title":"NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?","volume":"321","author":"Eras","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ajkd.2020.03.023_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40266-019-00660-1","article-title":"Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say?","volume":"36","author":"Cooper","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1053\/j.ajkd.2020.03.023_bib13","first-page":"F352","article-title":"Selective\u00a0targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival","volume":"277","author":"Hao","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"N\u00f8rregaard","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"10.1053\/j.ajkd.2020.03.023_bib15","first-page":"F148","article-title":"Angiotensin II induces TNF production by the thick ascending limb: functional implications","volume":"274","author":"Ferreri","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib16","first-page":"F360","article-title":"Cyclooxygenase-2 expression and function in the medullary thick ascending limb","volume":"277","author":"Ferreri","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.HYP.35.1.68","article-title":"Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells","volume":"35","author":"Ohnaka","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2020.03.023_bib18","doi-asserted-by":"crossref","first-page":"22574","DOI":"10.1016\/S0021-9258(17)31684-8","article-title":"Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesangial cells","volume":"269","author":"Kester","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.ajkd.2020.03.023_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2796.2003.01146.x","article-title":"Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors","volume":"253","author":"Gambaro","year":"2003","journal-title":"J\u00a0Intern Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib20","first-page":"F181","article-title":"Prostanoid biosynthesis and mechanisms of action","volume":"263","author":"Smith","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib21","first-page":"214","article-title":"Clinical acute renal failure with nonsteroidal anti-inflammatory drugs","volume":"15","author":"Palmer","year":"1995","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib22","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2020.03.023_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib24","first-page":"137","article-title":"Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted","volume":"6","author":"Launay-Vacher","year":"2005","journal-title":"J\u00a0Pain"},{"key":"10.1053\/j.ajkd.2020.03.023_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198905113201908","article-title":"Analgesic nephropathy--a preventable renal disease","volume":"320","author":"Bennett","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MNH.0000000000000473","article-title":"The case for cautious consumption: NSAIDs in chronic kidney disease","volume":"28","author":"Sriperumbuduri","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ajkd.2020.03.023_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1185\/030079902125000354","article-title":"A\u00a0comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents","volume":"18","author":"Gertz","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.ajkd.2020.03.023_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","article-title":"The clinical significance of inhibition of renal prostaglandin synthesis","volume":"32","author":"Patrono","year":"1987","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2020.03.023_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0272-6386(03)00647-4","article-title":"Analgesic use and change in kidney function in apparently healthy men","volume":"42","author":"Kurth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","article-title":"Lifetime nonnarcotic analgesic use and decline in renal function in women","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/j.ajkd.2007.12.014","article-title":"Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults","volume":"51","author":"Agodoa","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0272-6386(12)80657-3","article-title":"Can ibuprofen cause acute renal failure in a normal individual? A case of acute overdose","volume":"18","author":"Perazella","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.023_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/gfh033","article-title":"Acute tubulointerstitial nephritis associated with celecoxib","volume":"19","author":"Brewster","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2020.03.023_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9343(01)00757-4","article-title":"Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs","volume":"111","author":"Perazella","year":"2001","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00369-1","article-title":"Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2\u2013selective inhibition","volume":"107","author":"Brater","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/emermed-2016-206353","article-title":"Ibuprofen versus placebo effect on acute kidney injury in ultramarathons: a randomised controlled trial","volume":"34","author":"Lipman","year":"2017","journal-title":"Emerg Med J"},{"key":"10.1053\/j.ajkd.2020.03.023_bib49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinte.1983.00350060052007","article-title":"Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs","volume":"143","author":"Blackshear","year":"1983","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.023_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a010234","article-title":"Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons","volume":"151","author":"Griffin","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin\u2013angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2020.03.023_bib51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gfz062","article-title":"Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study","volume":"34","author":"Nash","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2020.03.023_bib55","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/jamainternmed.2018.4273","article-title":"Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease","volume":"178","author":"Bouck","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib56","article-title":"Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission","volume":"2","author":"Joseph Hwang","year":"2012","journal-title":"BMJ Open"},{"key":"10.1053\/j.ajkd.2020.03.023_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002011","article-title":"Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission","volume":"2","author":"Fleet","year":"2012","journal-title":"BMJ Open"},{"key":"10.1053\/j.ajkd.2020.03.023_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2020.03.023_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI5505","article-title":"Angiotensin II attenuates renal cortical cyclooxygenase-2 expression","volume":"103","author":"Cheng","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ajkd.2020.03.023_bib44","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1097\/TP.0000000000002689","article-title":"Long-term assessment of NSAID prescriptions and potential nephrotoxicity risk in adult kidney transplant recipients","volume":"103","author":"Chiasson","year":"2019","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2020.03.023_bib52","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/jcph.1264","article-title":"Calcineurin inhibitor and nonsteroidal anti-inflammatory drug\u00a0interaction: implications of changes in renal function associated with concurrent use","volume":"58","author":"Delzer","year":"2018","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40266-019-00664-x","article-title":"Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis","volume":"36","author":"Curtis","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1053\/j.ajkd.2020.03.023_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1365-2125.2008.03121.x","article-title":"Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases","volume":"65","author":"McGettigan","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.22614","article-title":"Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective cyclooxygenase 2 inhibitors: a class effect?","volume":"57","author":"Hudson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2020.03.023_bib61","doi-asserted-by":"crossref","first-page":"i4857","DOI":"10.1136\/bmj.i4857","article-title":"Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study","volume":"354","author":"Arf\u00e8","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2020.03.023_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ackd.2017.08.001","article-title":"Sodium homeostasis in chronic kidney disease","volume":"24","author":"Soi","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14740338.1.1.53","article-title":"COX-2 selective inhibitors: analysis of the renal effects","volume":"1","author":"Perazella","year":"2002","journal-title":"Expert Opin Drug Saf"},{"key":"10.1053\/j.ajkd.2020.03.023_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5049\/EBP.2007.5.2.116","article-title":"Electrolyte and acid-base disturbances associated with non-steroidal anti-inflammatory drugs","volume":"5","author":"Kim","year":"2007","journal-title":"Electrolyte Blood Press"},{"key":"10.1053\/j.ajkd.2020.03.023_bib65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1249\/01.mss.0000210209.40694.09","article-title":"NSAID use increases the risk of developing hyponatremia during an Ironman triathlon","volume":"38","author":"Wharam","year":"2006","journal-title":"Med Sci Sports Exerc"},{"key":"10.1053\/j.ajkd.2020.03.023_bib66","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.V541106","article-title":"Increased susceptibility to thiazide-induced hyponatremia in the elderly","volume":"5","author":"Clark","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib67","doi-asserted-by":"crossref","first-page":"167267","DOI":"10.1155\/2013\/167267","article-title":"Ibuprofen can induce syndrome of inappropriate diuresis in healthy young patients","volume":"2013","author":"Roche","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib68","first-page":"818259","article-title":"Syndrome of inappropriate antidiuretic hormone secretion and ibuprofen, a rare association to be considered: role of tolvaptan","volume":"2013","author":"Artom","year":"2013","journal-title":"Case Rep Endocrinol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib69","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000326902","article-title":"Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease","volume":"34","author":"Meijer","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1053\/j.ajkd.2020.03.023_bib70","doi-asserted-by":"crossref","first-page":"l1774","DOI":"10.1136\/bmj.l1774","article-title":"Hyponatraemia in primary care","volume":"365","author":"Jacob","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2020.03.023_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0002-9343(00)00496-4","article-title":"Drug-induced hyperkalemia: old culprits and new offenders","volume":"109","author":"Perazella","year":"2000","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.023_bib72","first-page":"F116","article-title":"Eicosanoids modulate apical Ca (2+)-dependent K+ channels in cultured rabbit principal cells","volume":"263","author":"Ling","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ajkd.2012.02.328","article-title":"Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study","volume":"60","author":"Lafrance","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ejhf.226","article-title":"Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case--control study in UK general practice","volume":"17","author":"Michel","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.ajkd.2020.03.023_bib75","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A\u00a0meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.023_bib76","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib77","doi-asserted-by":"crossref","first-page":"993","DOI":"10.17219\/acem\/37357","article-title":"The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure","volume":"23","author":"Kalafutova","year":"2014","journal-title":"Adv Clin Exp Med"},{"issue":"5B","key":"10.1053\/j.ajkd.2020.03.023_bib78","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(99)00113-8","article-title":"Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications","volume":"106","author":"Whelton","year":"1999","journal-title":"Am J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.023_bib79","first-page":"e372","article-title":"Interaction between antihypertensives and NSAIDS in primary care: a controlled trial","volume":"15","author":"Pavlicevic","year":"2008","journal-title":"Can J Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib80","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/eurheartj\/ehx508","volume":"38","author":"Ruschitzka","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2020.03.023_bib81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2020.03.023_bib82","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.hjh.0000239278.82196.a5","article-title":"The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults","volume":"24","author":"Wilson","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1053\/j.ajkd.2020.03.023_bib83","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.3329","article-title":"Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury","volume":"21","author":"Leonard","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.ajkd.2020.03.023_bib84","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib85","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2215\/CJN.08090719","article-title":"NSAIDs and nephrotic syndrome","volume":"14","author":"M\u00e9rida","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib86","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2215\/CJN.14331218","article-title":"Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users","volume":"14","author":"Bakhriansyah","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib87","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1552-4604.1991.tb03743.x","article-title":"Nonsteroidal anti-inflammatory drugs: effects on kidney function","volume":"31","author":"Whelton","year":"1991","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1053\/j.ajkd.2020.03.023_bib88","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-115-3-165","article-title":"Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease","volume":"115","author":"Sandler","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jama.286.3.315","article-title":"Analgesic use and renal function in men","volume":"286","author":"Rexrode","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2020.03.023_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib91","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00000441-199004000-00002","article-title":"Ibuprofen-associated renal impairment in a large general internal medicine practice","volume":"299","author":"Murray","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ajkd.2020.03.023_bib93","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2013-204078","article-title":"Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study","volume":"74","author":"M\u00f6ller","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2020.03.023_bib94","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/fampra\/cms086","article-title":"Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review","volume":"30","author":"Nderitu","year":"2013","journal-title":"Fam Pract"},{"key":"10.1053\/j.ajkd.2020.03.023_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7896","article-title":"Association of nonsteroidal anti-inflammatory drug prescriptions with kidney disease among active young and middle-aged adults","volume":"2","author":"Nelson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.ajkd.2020.03.023_bib95","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ckj\/sfx080","article-title":"2017 Update on pain management in patients with chronic kidney disease","volume":"10","author":"Pham","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.ajkd.2020.03.023_bib96","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00007611-199312000-00025","article-title":"NSAID nephrotoxicity revisited: acute renal failure due to parenteral ketorolac","volume":"86","author":"Perazella","year":"1993","journal-title":"South Med J"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2020.03.023_bib97","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/pme.12288","article-title":"Topical NSAID formulations","volume":"14","author":"McPherson","year":"2013","journal-title":"Pain Med"},{"key":"10.1053\/j.ajkd.2020.03.023_bib98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.03.008","article-title":"Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis","volume":"143","author":"Simon","year":"2009","journal-title":"Pain"},{"key":"10.1053\/j.ajkd.2020.03.023_bib99","first-page":"2002","article-title":"Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial","volume":"31","author":"Tugwell","year":"2004","journal-title":"J\u00a0Rheumatol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620307241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:30:22Z","timestamp":1759462222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620307241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0272638620307241"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NSAIDs in CKD: Are They Safe?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}